TALDO1
protein-codingtransaldolase 1
Gene summary
Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway providing ribose-5-phosphate for nucleic acid synthesis and NADPH for lipid biosynthesis. This pathway can also maintain glutathione at a reduced state and thus protect sulfhydryl groups and cellular integrity from oxygen radicals. The functional gene of transaldolase 1 is located on chromosome 11 and a pseudogene is identified on chromosome 1 but there are conflicting map locations. The second and third exon of this gene were developed by insertion of a retrotransposable element. This gene is thought to be involved in multiple sclerosis. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011624
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011624
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011624
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011624
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011624
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Craniofacial; Dermatologic; Gastrointestinal; Hematologic; Renal
Intervention: Biochemical; Pharmacogenomic
Rationale: The use of N--acetylcysteine therapy has been reported as beneficial related to at least laboratory-based parameters; Studies have suggested that individuals may be sensitive to acetaminophen therapy, and that this medication should be avoided due to the risk of toxicity
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TALDO1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006755.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 69 | 2 | 80 | ||
| missense | 3 | 6 | 110 | 6 | 1 | 126 |
| nonsense | 4 | 2 | 2 | 8 | ||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 4 | 2 | 11 | ||
| splice donor/acceptor (+/-2bp) | 5 | 4 | 9 | |||
| Total | 12 | 17 | 128 | 75 | 3 | 235 |
Highest pathogenic variant AF is 0.000042766722
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006746.1 | 8 | MANE Select | |
| Ensembl | ENSP00000321259.3 | 8 | MANE Select | |
| Ensembl | ENSP00000435042.1 | 2 | Standard | |
| Ensembl | ENSP00000437098.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pentose phosphate pathway - Homo sapiens (human)
- Warburg Effect
- Pentose Phosphate Pathway
- Glucose-6-phosphate dehydrogenase deficiency
- Ribose-5-phosphate isomerase deficiency
Biological Process
- carbohydrate metabolic process
- xylulose biosynthetic process
- fructose 6-phosphate metabolic process
- pentose-phosphate shunt
- pentose-phosphate shunt, non-oxidative branch
Molecular Function
- sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity
- protein binding
- monosaccharide binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000319006
- Coding exons
- 8
- Length
- 17696
- Individuals with no LoFs
- 125721
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 27
- Defined
- 125748
- p
- 0.000107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.13 | 239 | 195 | 1.23 | 0.0000124 | 2194 |
| Missense (PolyPhen) | 77 | 67.707 | 1.1373 | 836 | ||
| Synonymous | -0.957 | 93 | 82.0 | 1.13 | 0.00000578 | 648 |
| Loss of Function | 1.22 | 11 | 16.3 | 0.673 | 8.94e-7 | 197 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transaldolase is important for the balance of metabolites in the pentose-phosphate pathway.;
- Disease
- DISEASE: Transaldolase deficiency (TALDOD) [MIM:606003]: An inborn error of the pentose phosphate pathway resulting in early-onset multisystem disease. Clinical features include growth retardation, dysmorphic features, cutis laxa, congenital heart disease, hepatosplenomegaly, telangiectases of the skin, pancytopenia, and bleeding tendency. {ECO:0000269|PubMed:11283793}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.459
Intolerance Scores
- LoFtool
- 0.165
- RVIS EVS
- -0.73
- RVIS percentile EVS
- 14.02
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.979
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |